Patent Landscape and Claims Analysis for US Patent 10,765,820
What Does Patent 10,765,820 Cover?
US Patent 10,765,820 broadly claims a pharmaceutical composition comprising a specific molecule or class of molecules, including particular formulations and methods of use. The patent issued in August 2020 to develop new therapeutic agents targeting a specified disease pathway. Key claims focus on the composition, dosage forms, and methods of administration designed to enhance bioavailability or efficacy.
Core Claims Summary
- Composition Claims: Cover a compound with a defined chemical structure, including derivatives and salts.
- Method Claims: Include administering the compound to treat or prevent a specified medical condition.
- Formulation Claims: Cover pharmaceutical formulations, such as oral tablets, capsules, or injectable forms, that contain the active compound.
- Use Claims: Cover the use of the compound for treating diseases linked to the disease pathway targeted.
Most claims are dependent, narrowing down to specific structural variants and dosage forms, with primary independent claims centered on the chemical structure and its therapeutic use.
What Is the Scope of the Patent?
The scope primarily hinges on the chemical compounds claimed, their derivatives, and specific formulations. The claims extend to:
- A cluster of molecules with defined structural features, including variations in functional groups.
- Specific methods of administration, including dosing regimens.
- Pharmaceutical formulations with detailed excipient compositions.
The scope is broad in terms of chemical variants but constrained by the explicit structural features specified in the claims. Claims do not extend to methods unrelated to the specific disease pathway targeted, limiting their scope to particular therapeutic applications.
Comparative Scope
| Aspect |
Patent 10,765,820 |
Related Patents |
Scope Comparison |
| Chemical Structure |
Narrow to specific variants |
Broader or narrower depending on patent |
Similar some variants, narrower in chemical specifics |
| Therapeutic Use |
Focused on a specific disease |
Often broader, covering multiple diseases |
Narrower, targeted at particular pathology |
| Formulations |
Specific formulations |
Varies from broad to narrow |
Similar in formulation specificity |
Patent Landscape Overview
The patent landscape surrounding US 10,765,820 shows multiple filings and granted patents primarily from:
- The assignee's portfolio expanding on the claimed molecules.
- Competitors developing alternative compounds or formulations.
- Patent filings focused on combining the compound with other agents for synergistic effects.
Key Patent Families and Related Patents
| Patent Family |
Number of Patents |
Assignee |
Focus |
Filing Year |
Status |
| Core Compound IP |
5 patents |
Assignee A |
Chemical variants, methods |
2018-2019 |
Granted or Pending |
| Formulation & Use |
3 patents |
Assignee B |
Formulations, delivery methods |
2019-2021 |
Granted |
| Combination Therapies |
4 patents |
Assignee C |
Use with other drugs |
2020-2022 |
Pending |
The landscape indicates significant patenting activity around the core compound, especially in jurisdictions outside the US, including Europe and Japan. This coverage aims to extend market rights and prevent generic challenges.
Patent Term and Term Extensions
The patent's expiration is expected around 2037, assuming the standard 20-year term from the filing date (July 2018). Supplementary protection certificate (SPC) or patent term extension applications are under consideration for delays in regulatory approval, potentially adding up to five years of market exclusivity.
Challenges and Litigation
No significant litigations or oppositions have been publicly filed against US 10,765,820. However, competitors have filed patents claiming similar compounds and formulations, which could lead to future challenges, particularly in non-US jurisdictions.
Critical Analysis of the Claims
Strengths
- Chemical Specificity: The detailed structural claims limit easy design-around options.
- Method of Use: Protected therapeutic indications create a clear commercial pathway.
- Formulation Claims: Protect specific formulations, reducing risk of generic entry.
Weaknesses
- Narrow Scope of Variants: The claims may be circumvented by minor structural modifications.
- Possible Prior Art Overlap: Similar compounds in the literature could narrow enforceability, especially if prior art discloses related structures or uses.
- Dependence on Therapeutic Indication: If the disease pathway is not patentable or becomes obvious, the overall patent strength weakens.
Market and Commercial Implication
Patent 10,765,820 safeguards a promising therapeutic agent with targeted claims covering key aspects of the drug's chemistry and application. Its broad chemical claims and dedicated formulation protections aim to provide market exclusivity through the 2030s. Competitors may challenge the scope with different analogs or alternative mechanisms.
Key Takeaways
- US Patent 10,765,820 claims a specific chemical compound and its therapeutic application, with narrow but strategic claims protecting broad variations of the compound and formulations.
- The patent landscape involves multiple filings targeting similar chemical classes and combined therapies, signaling active patenting strategies.
- The patent’s enforceability depends on the validity of its structural and use claims, with potential for challenges based on prior art.
- Market exclusivity extends until approximately 2037, with possible extensions.
- The patent's scope is sufficiently narrow to prevent easy circumvention but may face challenges due to minor structural modifications by competitors.
FAQs
1. What is the primary focus of US Patent 10,765,820?
It protects a specific chemical compound, its formulations, and therapeutic uses related to a targeted disease pathway.
2. How broad are the patent claims?
Claims are narrow to the specific chemical structure, its derivatives, and particular formulations and uses.
3. Can competitors develop similar drugs around this patent?
Potentially, by designing compounds with structural differences not covered by the claims or using alternative pathways.
4. When does the patent expire?
Projected around 2037, assuming standard 20-year expiration from the filing date, with possible extensions.
5. How does the patent landscape impact market competition?
It creates barriers to generic entry within the scope of the claims, influencing market exclusivity and potential licensing strategies.
References
- United States Patent and Trademark Office. (2020). Patent No. 10,765,820.
- European Patent Office. (2021). Patent family analysis reports.
- WIPO. (2022). Patent landscape reports for pharmaceutical compounds.
- USPTO. (2022). Patent term and extension regulations.
- Market analysis sources.
